In intra-abdominal infections, what is the role of source control in antibiotic management?

• A. It is optional and rarely affects outcomes
• B. It should be delayed until after antibiotic optimization
• C. It is essential and allows narrowing therapy once achieved
• D. It is only for immunocompromised patients

Answer: (C)

Intra-abdominal infections require not only antibiotics but also removal or definitive control of the infection’s source. When the source—such as an abscess, perforation with contamination, or obstructed/necrotic tissue—is adequately controlled, the bacterial load drops and the environment becomes more favorable for antibiotics to work. This clearance of the source makes it possible to de-escalate therapy to a narrower, targeted antibiotic regimen once culture results and clinical response are known. Early and effective source control is associated with better outcomes and often shorter courses of broad-spectrum therapy.

Delaying source control or treating it as optional misreads the reality that antibiotics alone cannot reliably eradicate infections with a persistent nidus. It’s not limited to immunocompromised patients; all patients benefit from prompt source control because it directly influences the success of medical therapy.